Clinical characteristics and outcome of COVID-19 in patients with rheumatic diseases

{ 'indexed': { 'date-parts': [[2023, 12, 23]], 'date-time': '2023-12-23T06:03:04Z', 'timestamp': 1703311384073}, 'reference-count': 28, 'publisher': 'Springer Science and Business Media LLC', 'issue': '6', 'license': [ { 'start': { 'date-parts': [[2021, 4, 15]], 'date-time': '2021-04-15T00:00:00Z', 'timestamp': 1618444800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.springer.com/tdm'}, { 'start': { 'date-parts': [[2021, 4, 15]], 'date-time': '2021-04-15T00:00:00Z', 'timestamp': 1618444800000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://www.springer.com/tdm'}], 'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2021, 6]]}, 'DOI': '10.1007/s00296-021-04857-9', 'type': 'journal-article', 'created': {'date-parts': [[2021, 4, 15]], 'date-time': '2021-04-15T10:34:55Z', 'timestamp': 1618482895000}, 'page': '1097-1103', 'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 18, 'title': 'Clinical characteristics and outcome of COVID-19 in patients with rheumatic diseases', 'prefix': '10.1007', 'volume': '41', 'author': [ { 'ORCID': 'http://orcid.org/0000-0001-8696-7930', 'authenticated-orcid': False, 'given': 'Zeyad A.', 'family': 'Alzahrani', 'sequence': 'first', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-3064-7097', 'authenticated-orcid': False, 'given': 'Khalid Abdullah', 'family': 'Alghamdi', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-0557-0219', 'authenticated-orcid': False, 'given': 'Ahmed Saeed', 'family': 'Almaqati', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2021, 4, 15]]}, 'reference': [ { 'issue': '10223', 'key': '4857_CR1', 'doi-asserted-by': 'publisher', 'first-page': '497', 'DOI': '10.1016/S0140-6736(20)30183-5', 'volume': '395', 'author': 'C Huang', 'year': '2020', 'unstructured': 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al (2020) Clinical ' 'features of patients infected with 2019 novel coronavirus in Wuhan, ' 'China. Lancet (London, England) 395(10223):497–506', 'journal-title': 'Lancet (London, England)'}, { 'key': '4857_CR2', 'unstructured': 'COVID-19 Map—Johns Hopkins Coronavirus Resource Center 2021. ' 'https://coronavirus.jhu.edu/map.html. Accessed 28 Jan 2021'}, { 'key': '4857_CR3', 'unstructured': 'World Health Organization (2020) Clinical management of COVID-19: ' 'interim guidance, 27 May 2020. World Health Organization. ' 'https://apps.who.int/iris/handle/10665/332196. Accessed 28 Jan 2021'}, { 'issue': '6', 'key': '4857_CR4', 'doi-asserted-by': 'publisher', 'first-page': '639', 'DOI': '10.1016/j.jinf.2020.03.019', 'volume': '80', 'author': 'L Wang', 'year': '2020', 'unstructured': 'Wang L, He W, Yu X, Hu D, Bao M, Liu H et al (2020) Coronavirus disease ' '2019 in elderly patients: characteristics and prognostic factors based ' 'on 4-week follow-up. J Infect 80(6):639–645', 'journal-title': 'J Infect'}, { 'issue': '12', 'key': '4857_CR5', 'doi-asserted-by': 'publisher', 'first-page': '1544', 'DOI': '10.1136/annrheumdis-2020-218296', 'volume': '79', 'author': 'JL Pablos', 'year': '2020', 'unstructured': 'Pablos JL, Galindo M, Carmona L, Lledó A, Retuerto M, Blanco R et al ' '(2020) Clinical outcomes of hospitalised patients with COVID-19 and ' 'chronic inflammatory and autoimmune rheumatic diseases: a multicentric ' 'matched cohort study. Ann Rheum Dis 79(12):1544–1549', 'journal-title': 'Ann Rheum Dis'}, { 'issue': '1', 'key': '4857_CR6', 'doi-asserted-by': 'publisher', 'first-page': '85', 'DOI': '10.1056/NEJMc2009567', 'volume': '383', 'author': 'R Haberman', 'year': '2020', 'unstructured': 'Haberman R, Axelrad J, Chen A, Castillo R, Yan D, Izmirly P et al (2020) ' 'Covid-19 in immune-mediated inflammatory diseases—case series from New ' 'York. N Engl J Med 383(1):85–88', 'journal-title': 'N Engl J Med'}, { 'issue': '7', 'key': '4857_CR7', 'doi-asserted-by': 'publisher', 'first-page': '859', 'DOI': '10.1136/annrheumdis-2020-217871', 'volume': '79', 'author': 'M Gianfrancesco', 'year': '2020', 'unstructured': 'Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L ' 'et al (2020) Characteristics associated with hospitalisation for ' 'COVID-19 in people with rheumatic disease: data from the COVID-19 Global ' 'Rheumatology Alliance physician-reported registry. Ann Rheum Dis ' '79(7):859–866', 'journal-title': 'Ann Rheum Dis'}, { 'key': '4857_CR8', 'doi-asserted-by': 'publisher', 'first-page': 'm1849', 'DOI': '10.1136/bmj.m1849', 'volume': '369', 'author': 'W Tang', 'year': '2020', 'unstructured': 'Tang W, Cao Z, Han M, Wang Z, Chen J, Sun W et al (2020) ' 'Hydroxychloroquine in patients with mainly mild to moderate coronavirus ' 'disease 2019: open label, randomised controlled trial. BMJ 369:m1849', 'journal-title': 'BMJ'}, { 'key': '4857_CR9', 'doi-asserted-by': 'publisher', 'unstructured': 'RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, ' 'Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, ' 'Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, ' 'Faust SN, Jaki T, Landray MJ (2021) Dexamethasone in hospitalized ' 'patients with Covid-19. N Engl J Med 384(8):693–704. ' 'https://doi.org/10.1056/NEJMoa2021436', 'DOI': '10.1056/NEJMoa2021436'}, { 'key': '4857_CR10', 'doi-asserted-by': 'publisher', 'unstructured': 'Malgie J, Schoones JW, Pijls BG (2020) Decreased mortality in COVID-19 ' 'patients treated with Tocilizumab: a rapid systematic review and ' 'meta-analysis of observational studies. Clin Infect Dis Sep 23:ciaa1445. ' 'https://doi.org/10.1093/cid/ciaa1445', 'DOI': '10.1093/cid/ciaa1445'}, { 'issue': '1', 'key': '4857_CR11', 'doi-asserted-by': 'publisher', 'first-page': '36', 'DOI': '10.1002/art.41469', 'volume': '73', 'author': 'M Putman', 'year': '2021', 'unstructured': 'Putman M, Chock YPE, Tam H, Kim AHJ, Sattui SE, Berenbaum F et al (2021) ' 'Antirheumatic disease therapies for the treatment of COVID-19: a ' 'systematic review and meta-analysis. Arthritis Rheumatol 73(1):36–47', 'journal-title': 'Arthritis Rheumatol'}, { 'key': '4857_CR12', 'unstructured': 'World Health Organization (2021) Men, ageing and health: achieving ' 'health across the life span. World Health Organization, Geneva. Accessed ' '27 Jan 2021'}, { 'key': '4857_CR13', 'doi-asserted-by': 'crossref', 'unstructured': 'FAI2R /SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors ' '(2020) Severity of COVID-19 and survival in patients with rheumatic and ' 'inflammatory diseases: data from the French RMD COVID-19 cohort of 694 ' 'patients. Ann Rheum Dis 80(4):527–538. (annrheumdis-2020-218310)', 'DOI': '10.1136/annrheumdis-2020-218310'}, { 'key': '4857_CR14', 'doi-asserted-by': 'crossref', 'unstructured': 'Strangfeld A, Schäfer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, ' 'Ljung L et al (2021) Factors associated with COVID-19-related death in ' 'people with rheumatic diseases: results from the COVID-19 Global ' 'Rheumatology Alliance physician-reported registry. Ann Rheum Dis ' '(2021:annrheumdis-2020-219498)', 'DOI': '10.1136/annrheumdis-2021-220134'}, { 'issue': '2', 'key': '4857_CR15', 'doi-asserted-by': 'publisher', 'first-page': 'e001332', 'DOI': '10.1136/rmdopen-2020-001332', 'volume': '6', 'author': 'R Hasseli', 'year': '2020', 'unstructured': 'Hasseli R, Mueller-Ladner U, Schmeiser T, Hoyer BF, Krause A, Lorenz HM ' 'et al (2020) National registry for patients with inflammatory rheumatic ' 'diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a ' 'valuable mean to gain rapid and reliable knowledge of the clinical ' 'course of SARS-CoV-2 infections in patients with IRD. RMD Open ' '6(2):e001332. https://doi.org/10.1136/rmdopen-2020-001332', 'journal-title': 'RMD Open'}, { 'issue': '10', 'key': '4857_CR16', 'doi-asserted-by': 'publisher', 'first-page': '1593', 'DOI': '10.1007/s00296-020-04676-4', 'volume': '40', 'author': 'F Montero', 'year': '2020', 'unstructured': 'Montero F, Martínez-Barrio J, Serrano-Benavente B, González T, Rivera J, ' 'Molina Collada J et al (2020) Coronavirus disease 2019 (COVID-19) in ' 'autoimmune and inflammatory conditions: clinical characteristics of poor ' 'outcomes. Rheumatol Int 40(10):1593–1598', 'journal-title': 'Rheumatol Int'}, { 'issue': '9', 'key': '4857_CR17', 'doi-asserted-by': 'publisher', 'first-page': '1653', 'DOI': '10.1093/ntr/ntaa082', 'volume': '22', 'author': 'R Patanavanich', 'year': '2020', 'unstructured': 'Patanavanich R, Glantz SA (2020) Smoking is associated with COVID-19 ' 'progression: a meta-analysis. Nicotine Tob Res 22(9):1653–1656', 'journal-title': 'Nicotine Tob Res'}, { 'issue': '9', 'key': '4857_CR18', 'doi-asserted-by': 'publisher', 'first-page': 'e557', 'DOI': '10.1016/S2665-9913(20)30227-7', 'volume': '2', 'author': 'J Zhong', 'year': '2020', 'unstructured': 'Zhong J, Shen G, Yang H, Huang A, Chen X, Dong L et al (2020) COVID-19 ' 'in patients with rheumatic disease in Hubei province, China: a ' 'multicentre retrospective observational study. Lancet Rheumatol ' '2(9):e557–e564', 'journal-title': 'Lancet Rheumatol'}, { 'issue': '11', 'key': '4857_CR19', 'doi-asserted-by': 'publisher', 'first-page': '1393', 'DOI': '10.1136/annrheumdis-2020-217984', 'volume': '79', 'author': 'DD Freites Nuñez', 'year': '2020', 'unstructured': 'Freites Nuñez DD, Leon L, Mucientes A, Rodriguez-Rodriguez L, Font ' 'Urgelles J, Madrid García A et al (2020) Risk factors for hospital ' 'admissions related to COVID-19 in patients with autoimmune inflammatory ' 'rheumatic diseases. Ann Rheum Dis 79(11):1393–1399', 'journal-title': 'Ann Rheum Dis'}, { 'issue': '9', 'key': '4857_CR20', 'doi-asserted-by': 'publisher', 'first-page': '1156', 'DOI': '10.1136/annrheumdis-2020-217888', 'volume': '79', 'author': "KM D'Silva", 'year': '2020', 'unstructured': 'D’Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Fu X, Gravallese EM et al ' '(2020) Clinical characteristics and outcomes of patients with ' 'coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative ' 'cohort study from a US “hot spot.” Ann Rheum Dis 79(9):1156–1162', 'journal-title': 'Ann Rheum Dis'}, { 'key': '4857_CR21', 'doi-asserted-by': 'crossref', 'unstructured': 'Fernandez-Gutierrez B, Leon L, Madrid A, Rodriguez-Rodriguez L, Freites ' 'D, Font J et al (2021) Hospital admissions in inflammatory rheumatic ' 'diseases during the peak of COVID-19 pandemic: incidence and role of ' 'disease-modifying agents. Ther Adv Musculoskelet Dis 13:1759720X20962692', 'DOI': '10.1177/1759720X20962692'}, { 'key': '4857_CR22', 'doi-asserted-by': 'crossref', 'unstructured': 'Fredi M, Cavazzana I, Moschetti L, Andreoli L, Franceschini F, Brescia ' 'Rheumatology C-SG (2020) COVID-19 in patients with rheumatic diseases in ' 'northern Italy: a single-centre observational and case-control study. ' 'Lancet Rheumatol 2(9):e549–e56', 'DOI': '10.1016/S2665-9913(20)30169-7'}, { 'issue': '2', 'key': '4857_CR23', 'doi-asserted-by': 'publisher', 'first-page': '243', 'DOI': '10.1007/s00296-020-04764-5', 'volume': '41', 'author': 'S Ahmed', 'year': '2021', 'unstructured': 'Ahmed S, Gasparyan AY, Zimba O (2021) Comorbidities in rheumatic ' 'diseases need special consideration during the COVID-19 pandemic. ' 'Rheumatol Int 41(2):243–256. https://doi.org/10.1007/s00296-020-04764-5', 'journal-title': 'Rheumatol Int'}, { 'issue': '1', 'key': '4857_CR24', 'doi-asserted-by': 'publisher', 'first-page': 'e001439', 'DOI': '10.1136/rmdopen-2020-001439', 'volume': '7', 'author': 'CS Santos', 'year': '2021', 'unstructured': 'Santos CS, Férnandez XC, Moriano Morales C, Álvarez ED, Álvarez Castro ' 'C, López Robles A et al (2021) Biological agents for rheumatic diseases ' 'in the outbreak of COVID-19: friend or foe? RMD Open 7(1):e001439', 'journal-title': 'RMD Open'}, { 'issue': '9', 'key': '4857_CR25', 'doi-asserted-by': 'publisher', 'first-page': '2789', 'DOI': '10.1007/s10067-020-05301-2', 'volume': '39', 'author': 'CS Santos', 'year': '2020', 'unstructured': 'Santos CS, Morales CM, Álvarez ED, Castro CÁ, Robles AL, Sandoval TP ' '(2020) Determinants of COVID-19 disease severity in patients with ' 'underlying rheumatic disease. Clin Rheumatol 39(9):2789–2796', 'journal-title': 'Clin Rheumatol'}, { 'key': '4857_CR26', 'doi-asserted-by': 'publisher', 'first-page': '515', 'DOI': '10.1590/1516-3180.2020.0421.r2.10092020', 'volume': '138', 'author': 'AP Rocha', 'year': '2020', 'unstructured': 'Rocha AP, Atallah ÁN, Pinto ACPN, Rocha-Filho CR, Milby KM, Civile VT et ' 'al (2020) COVID-19 and patients with immune-mediated inflammatory ' 'diseases undergoing pharmacological treatments: a rapid living ' 'systematic review. Sao Paulo Med J 138:515–520', 'journal-title': 'Sao Paulo Med J'}, { 'issue': '7', 'key': '4857_CR27', 'doi-asserted-by': 'publisher', 'first-page': '988', 'DOI': '10.1136/annrheumdis-2020-217948', 'volume': '79', 'author': 'C Sanchez-Piedra', 'year': '2020', 'unstructured': 'Sanchez-Piedra C, Diaz-Torne C, Manero J, Pego-Reigosa JM, Rúa-Figueroa ' 'Í, Gonzalez-Gay MA et al (2020) Clinical features and outcomes of ' 'COVID-19 in patients with rheumatic diseases treated with biological and ' 'synthetic targeted therapies. Ann Rheum Dis 79(7):988–990', 'journal-title': 'Ann Rheum Dis'}, { 'issue': '12', 'key': '4857_CR28', 'doi-asserted-by': 'publisher', 'first-page': '2015', 'DOI': '10.1007/s00296-020-04699-x', 'volume': '40', 'author': 'J Loarce-Martos', 'year': '2020', 'unstructured': 'Loarce-Martos J, García-Fernández A, López-Gutiérrez F, García-García V, ' 'Calvo-Sanz L, Del Bosque-Granero I et al (2020) High rates of severe ' 'disease and death due to SARS-CoV-2 infection in rheumatic disease ' 'patients treated with rituximab: a descriptive study. Rheumatol Int ' '40(12):2015–2021', 'journal-title': 'Rheumatol Int'}], 'container-title': 'Rheumatology International', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://link.springer.com/content/pdf/10.1007/s00296-021-04857-9.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/article/10.1007/s00296-021-04857-9/fulltext.html', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/content/pdf/10.1007/s00296-021-04857-9.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2022, 12, 24]], 'date-time': '2022-12-24T10:29:22Z', 'timestamp': 1671877762000}, 'score': 1, 'resource': {'primary': {'URL': 'https://link.springer.com/10.1007/s00296-021-04857-9'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 4, 15]]}, 'references-count': 28, 'journal-issue': {'issue': '6', 'published-print': {'date-parts': [[2021, 6]]}}, 'alternative-id': ['4857'], 'URL': 'http://dx.doi.org/10.1007/s00296-021-04857-9', 'relation': {}, 'ISSN': ['0172-8172', '1437-160X'], 'subject': ['Immunology', 'Immunology and Allergy', 'Rheumatology'], 'container-title-short': 'Rheumatol Int', 'published': {'date-parts': [[2021, 4, 15]]}, 'assertion': [ { 'value': '8 February 2021', 'order': 1, 'name': 'received', 'label': 'Received', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '1 April 2021', 'order': 2, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '15 April 2021', 'order': 3, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': 'This content has been made available to all.', 'name': 'free', 'label': 'Free to read'}]}